- Home
- SYRE vs CGBD Comparison
SYRE vs CGBD Comparison
Compare SYRE & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- CGBD
- Stock Information
- Founded
- SYRE 2013
- CGBD 2012
- Country
- SYRE United States
- CGBD United States
- Employees
- SYRE N/A
- CGBD N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- CGBD Finance: Consumer Services
- Sector
- SYRE Health Care
- CGBD Finance
- Exchange
- SYRE Nasdaq
- CGBD Nasdaq
- Market Cap
- SYRE 897.9M
- CGBD 1.0B
- IPO Year
- SYRE 2016
- CGBD 2017
- Fundamental
- Price
- SYRE $12.67
- CGBD $14.59
- Analyst Decision
- SYRE Buy
- CGBD Sell
- Analyst Count
- SYRE 8
- CGBD 2
- Target Price
- SYRE $50.00
- CGBD $17.00
- AVG Volume (30 Days)
- SYRE 899.5K
- CGBD 442.1K
- Earning Date
- SYRE 05-08-2025
- CGBD 05-06-2025
- Dividend Yield
- SYRE N/A
- CGBD 12.33%
- EPS Growth
- SYRE N/A
- CGBD N/A
- EPS
- SYRE N/A
- CGBD 1.58
- Revenue
- SYRE N/A
- CGBD $232,590,000.00
- Revenue This Year
- SYRE N/A
- CGBD $4.34
- Revenue Next Year
- SYRE N/A
- CGBD $2.48
- P/E Ratio
- SYRE N/A
- CGBD $9.26
- Revenue Growth
- SYRE N/A
- CGBD N/A
- 52 Week Low
- SYRE $10.91
- CGBD $13.12
- 52 Week High
- SYRE $40.49
- CGBD $18.74
- Technical
- Relative Strength Index (RSI)
- SYRE 36.18
- CGBD 38.77
- Support Level
- SYRE $12.04
- CGBD $13.69
- Resistance Level
- SYRE $13.29
- CGBD $14.44
- Average True Range (ATR)
- SYRE 1.27
- CGBD 0.75
- MACD
- SYRE 0.01
- CGBD -0.04
- Stochastic Oscillator
- SYRE 26.02
- CGBD 42.36
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.